IRCT20150101020514N31
Recruiting
Phase 1
Safety and effectiveness assessment of injectable suspension of Inshape x Radiance plus (Nano Darou Pajuhan Pardis)for the treatment of the back of hand wrinkles.”
ano Darou Pajouhan Pardis Company0 sites15 target enrollmentTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ano Darou Pajouhan Pardis Company
- Enrollment
- 15
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age over 30 years
- •Moderate to very severe degree of hand wrinkles based on MHGS criteria
- •Agree to use safe methods of contraception.
- •Signing an informed consent form and agreed to follow up.
Exclusion Criteria
- •History of type 1 allergic reactions or anaphylaxis reaction
- •Pregnant or lactating or planning to become pregnant in the near future while studying
- •Allergy or sensitivity to lidocaine
- •Use of antiplatelet drugs during 72 hours before treatment and anticoagulant drugs during 2 weeks before or during treatment.
- •Any abnormality or history of surgery on the back of hand
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Safety and effectiveness of injectable gel with the Perjunse brandSkin aging.IRCT20150101020514N24Pars Fardad Nano Technology Company30
Recruiting
Phase 2
Evaluating the safety and effectiveness of injectable gel with the W&O XtraIII brandIRCT20190210042676N30Ara Teb Gostar Soroush Company30
Not yet recruiting
Phase 2
Safety and effectiveness assessment of ATP POUYA gel for nasolabial folds correctioSkin aging.IRCT20150101020514N20Pouya Teb Tools Company30
Recruiting
Phase 1
Investigating the effect of stromal/mesenchymal stem cell-derived exosomes in patients with perianal fistulaIRCT20240128060828N1Tehran University of Medical Sciences30
Recruiting
Phase 2
Evaluation of an injectable solution with the brand name ®Embella in order to reduce submental fat.Submental fat.IRCT20190210042676N29Zist orchid pharmed Company20